| Cvs Pharmacy # 01434 | |
| 7939 New Hampshire Avenue, Langley Park, Maryland 20783 | |
| (301) 434-3121 |
| Name | Cvs Pharmacy # 01434 |
|---|---|
| Organization Name | Maryland Cvs Pharmacy Llc. |
| Location | 7939 New Hampshire Avenue, Langley Park, Maryland 20783 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (301) 434-3121 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Ventas, Inc. said today that the United States District Court for the Western District of Kentucky has ruled that Ventas may immediately collect the $102 million compensatory damages judgment against HCP, Inc. that it was awarded by a federal jury in 2009.
The news coverage of the deadly EHEC bacteria outbreak in Europe came as a bombshell. Ghent University (Belgium) examined 6132 reactions of Belgian newspaper readers after reading the first news reports.
A study looking at brain function in young, middle-aged and older adults has identified changes in brain activity that begin gradually in middle age - and which may explain why older adults find it difficult to concentrate in busy environments and filter out irrelevant information.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
› Verified 8 days ago
| NPI Number | 1770687691 |
| Organization Name | MARYLAND CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #01434 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7939 New Hampshire Ave, Hyattsville, MD 20783 |
| Phone Number | 301-434-3121 |
News Archive
Ventas, Inc. said today that the United States District Court for the Western District of Kentucky has ruled that Ventas may immediately collect the $102 million compensatory damages judgment against HCP, Inc. that it was awarded by a federal jury in 2009.
The news coverage of the deadly EHEC bacteria outbreak in Europe came as a bombshell. Ghent University (Belgium) examined 6132 reactions of Belgian newspaper readers after reading the first news reports.
A study looking at brain function in young, middle-aged and older adults has identified changes in brain activity that begin gradually in middle age - and which may explain why older adults find it difficult to concentrate in busy environments and filter out irrelevant information.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
› Verified 8 days ago
News Archive
Ventas, Inc. said today that the United States District Court for the Western District of Kentucky has ruled that Ventas may immediately collect the $102 million compensatory damages judgment against HCP, Inc. that it was awarded by a federal jury in 2009.
The news coverage of the deadly EHEC bacteria outbreak in Europe came as a bombshell. Ghent University (Belgium) examined 6132 reactions of Belgian newspaper readers after reading the first news reports.
A study looking at brain function in young, middle-aged and older adults has identified changes in brain activity that begin gradually in middle age - and which may explain why older adults find it difficult to concentrate in busy environments and filter out irrelevant information.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
› Verified 8 days ago
Cvs Pharmacy # 01434 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7939 New Hampshire Avenue, Langley Park, Maryland 20783 Phone: (301) 434-3121 |